title: Noncoding RNAs in Heart Failure.
abstract: Heart failure is a major contributor to the healthcare burden and mortality worldwide. Current treatment strategies are able to slow down the transition of healthy heart into the failing one; nevertheless better understanding of the complex genetic regulation of maladaptive remodeling in the failing heart is essential for new drug discovery. Noncoding RNAs are key epigenetic regulators of cardiac gene expression and thus significantly influence cardiac homeostasis and functions.In this chapter we will discuss characteristics of noncoding RNAs, especially miRNAs, long noncoding RNAs, and circular RNAs, and review recent evidences proving their profound involvement during different stages of heart failure progression. Several open questions still prevent the extensive use of noncoding RNA-modulating therapies in clinics; yet they are becoming an attractive target to define novel regulatory mechanisms in the heart. In-depth study of their interaction with gene networks will refine our current view of heart failure and revolutionize the drug development in coming years.
authors.affiliation: Institute of Molecular and Translational Therapeutic Strategies, IFBTx, Hannover Medical School, Hannover, Germany.
authors.forename: Seema
authors.initials: S
authors.lastname: Dangwal
authors.affiliation: Institute of Molecular and Translational Therapeutic Strategies, IFBTx, Hannover Medical School, Hannover, Germany.
authors.forename: Katharina
authors.initials: K
authors.lastname: Schimmel
authors.affiliation: Institute of Molecular and Translational Therapeutic Strategies, IFBTx, Hannover Medical School, Hannover, Germany.
authors.forename: Ariana
authors.initials: A
authors.lastname: Foinquinos
authors.affiliation: Institute of Molecular and Translational Therapeutic Strategies, IFBTx, Hannover Medical School, Hannover, Germany.
authors.forename: Ke
authors.initials: K
authors.lastname: Xiao
authors.affiliation: Institute of Molecular and Translational Therapeutic Strategies, IFBTx, Hannover Medical School, Hannover, Germany. thum.thomas@mh-hannover.de.
authors.forename: Thomas
authors.initials: T
authors.lastname: Thum
mesh_terms: D006332:Cardiomegaly / Q000150:complications / Q000235:genetics / Q000378:metabolism; D003324:Coronary Artery Disease / Q000150:complications / Q000235:genetics / Q000378:metabolism; D005786:Gene Expression Regulation; D006333:Heart Failure / Q000209:etiology / Q000235:genetics* / Q000378:metabolism / Q000628:therapy; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000235:genetics / Q000378:metabolism; D035683:MicroRNAs / Q000235:genetics / Q000378:metabolism; D017202:Myocardial Ischemia / Q000150:complications / Q000235:genetics / Q000378:metabolism; D012313:RNA / Q000235:genetics / Q000378:metabolism; D000079962:RNA, Circular; D062085:RNA, Long Noncoding / Q000235:genetics / Q000378:metabolism; D022661:RNA, Untranslated / Q000235:genetics* / Q000378:metabolism / Q000627:therapeutic use; D017423:Sequence Analysis, RNA
chemical_list: D035683:MicroRNAs; D000079962:RNA, Circular; D062085:RNA, Long Noncoding; D022661:RNA, Untranslated; D012313:RNA
keywords: Circular RNA; Heart failure; Long noncoding RNAs; miRNAs; ncRNA therapy